ISSCR News
ISSCR Shares Recommendations for Proposed Genome Editing Registry with WHO
In a letter to Justice Edwin Cameron and Margaret Ann Hamburg, Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing, World Health Organization (WHO), the ISSCR shared its recommendations regarding plans to create a genome editing registry. The recommendations are intended to help to ensure that the proposed registry attracts legitimate submissions of fundamental and preclinical research and avoid abuse by businesses seeking to prematurely commercialize genome editing technologies.
Member Spotlight: Allon Klein, PhD
“It is hard for me to choose just a single most-rewarding aspect to our work. Probably it is the privilege of working with a brilliant, diverse, and compassionate group of lab members”.
Member Spotlight: Raj Kannan, PhD
“My lab is primarily interested in developing molecularly guided cancer prevention approaches for individuals at high-risk for developing breast and ovarian cancer”.
ISSCR and 100 Scientific Organizations Urge the Administration to Lift the Restrictions on Fetal Tissue Research
Skokie, IL – The ISSCR and 100 scientific and medical organizations united to impress upon the U.S. Administration to remove the restrictions on research using fetal tissue in order to allow crucial research into COVID-19 treatments and other diseases to move forward during this unprecedented global public health crisis.
ISSCR Announces Endorsement for California Initiative to Fund Stem Cell Research
The ISSCR announces its endorsement for the California initiative to invest $5.5 billion in stem cell research to continue the research and development of new therapies for life-threatening and devastating diseases. The new initiative will build on the historic $3 billion investment made by California in 2004, which created the California Institute for Regenerative Medicine (CIRM) and established the state as a leader in the field. While stem cell research holds enormous potential, more research is needed to develop and test safe and effective stem cell-based treatments…
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .